Role for Growth Regulation by Estrogen in Breast Cancer 1 (GREB1) in Hormone-Dependent Cancers

被引:46
作者
Cheng, Meng [1 ]
Michalski, Stephanie [1 ]
Kommagani, Ramakrishna [1 ]
机构
[1] Washington Univ, Sch Med, Dept Obstet & Gynecol, Ctr Reprod Hlth Sci, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
GREB1; steroid hormone; estrogen; progesterone; androgen; breast cancer; ovarian cancer; prostate cancer; HISTONE METHYLTRANSFERASE EZH2; STEROID-RECEPTOR COACTIVATOR-3; PROSTATE-CANCER; GENE-EXPRESSION; OVARIAN-CANCER; SERTOLI-CELLS; MAMMARY-GLAND; THERAPEUTIC TARGET; PROTEIN EXPRESSION; RESPONSE ELEMENTS;
D O I
10.3390/ijms19092543
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Sex hormones play important roles in the onset and progression of several cancers, such as breast, ovarian, and prostate cancer. Although drugs targeting sex hormone function are useful in treating cancer, tumors often develop resistance. Thus, we need to define the downstream effectors of sex hormones in order to develop new treatment strategies for these cancers. Recent studies unearthed one potential mediator of steroid hormone action in tumors: growth regulation by estrogen in breast cancer 1 (GREB1). GREB1 is an early estrogen-responsive gene, and its expression is correlated with estrogen levels in breast cancer patients. Additionally, GREB1 responds to androgen in prostate cancer cells, and can stimulate the proliferation of breast, ovarian, and prostate cancer cells. Recent studies have shown that GREB1 also responds to progesterone in human endometrial cells, suggesting that GREB1 is a pan steroid-responsive gene. This mini-review examines evidence that GREB1 participates in several hormone-dependent cancers and could be targeted to treat these cancers.
引用
收藏
页数:14
相关论文
共 98 条
[31]   PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling [J].
Ferreira, Luciana Bueno ;
Palumbo, Antonio ;
de Mello, Kivvi Duarte ;
Sternberg, Cinthya ;
Caetano, Mauricio S. ;
de Oliveira, Felipe Leite ;
Neves, Adriana Freitas ;
Nasciutti, Luiz Eurico ;
Goulart, Luiz Ricardo ;
Pereira Gimba, Etel Rodrigues .
BMC CANCER, 2012, 12
[32]   Expression of SRC-1, AIB1, and PEA3 in HER2 mediated endocrine resistant breast cancer; a predictive role for SRC-1 [J].
Fleming, FJ ;
Myers, E ;
Kelly, G ;
Crotty, TB ;
McDermott, EW ;
O'Higgins, NJ ;
Hill, ADK ;
Young, LS .
JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (10) :1069-1074
[33]   The Nottingham Prognostic Index: five- and ten-year data for all-cause Survival within a Screened Population [J].
Fong, Y. ;
Evans, J. ;
Brook, D. ;
Kenkre, J. ;
Jarvis, P. ;
Gower-Thomas, K. .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2015, 97 (02) :137-139
[34]   Functional evaluation of genetic variants associated with endometriosis near GREB1 [J].
Fung, Jenny N. ;
Holdsworth-Carson, Sarah J. ;
Sapkota, Yadav ;
Zhao, Zhen Zhen ;
Jones, Lincoln ;
Girling, Jane E. ;
Paiva, Premila ;
Healey, Martin ;
Nyholt, Dale R. ;
Rogers, Peter A. W. ;
Montgomery, Grant W. .
HUMAN REPRODUCTION, 2015, 30 (05) :1263-1275
[35]  
Ghosh MG, 2000, CANCER RES, V60, P6367
[36]   Serum estradiol levels associated with specific gene expression patterns in normal breast tissue and in breast carcinomas [J].
Haakensen, Vilde D. ;
Bjoro, Trine ;
Lueders, Torben ;
Riis, Margit ;
Bukholm, Ida K. ;
Kristensen, Vessela N. ;
Troester, Melissa A. ;
Homen, Marit M. ;
Ursin, Giske ;
Borresen-Dale, Anne-Lise ;
Helland, Aslaug .
BMC CANCER, 2011, 11
[37]   GREB1 isoforms regulate proliferation independent of ERα co-regulator activities in breast cancer [J].
Haines, Corinne N. ;
Braunreiter, Kara M. ;
Mo, Xiaokui Molly ;
Burd, Craig J. .
ENDOCRINE-RELATED CANCER, 2018, 25 (07) :735-746
[38]   GREB1 genetic variants are associated with bone mineral density in Caucasians [J].
Hegarty, Kevin G. ;
Drummond, Frances J. ;
Daly, Mary ;
Shanahan, Fergus ;
Molloy, Michael G. .
JOURNAL OF BONE AND MINERAL METABOLISM, 2018, 36 (02) :189-199
[39]   Correlation of GREB1 mRNA with protein expression in breast cancer: validation of a novel GREB1 monoclonal antibody [J].
Hnatyszyn, H. J. ;
Liu, M. ;
Hilger, A. ;
Herbert, L. ;
Gomez-Fernandez, C. R. ;
Jorda, M. ;
Thomas, D. ;
Rae, J. M. ;
El-Ashry, D. ;
Lippman, M. E. .
BREAST CANCER RESEARCH AND TREATMENT, 2010, 122 (02) :371-380
[40]  
Hodgkinson K., 2018, ONCOGENE